Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 11:37 am Sale | 2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX | JANUS HENDERSON GROUP PLC JHG | 17,839 0.000% | -4,781,513 (-99.63%) | Filing History |
| 2025-02-14 10:26 am Sale | 2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX | Avidity Partners Management LP | 2,841,024 4.200% | -749,402 (-20.87%) | Filing History |
| 2024-11-14 6:14 pm Purchase | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | Avidity Partners Management LP | 3,590,426 5.300% | 3,590,426 (New Position) | Filing History |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | COMMODORE CAPITAL LP | 3,350,000 4.960% | 3,350,000 (New Position) | Filing History |
| 2024-11-14 10:24 am Purchase | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | JANUS HENDERSON GROUP PLC JHG | 4,799,352 7.100% | 4,799,352 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | BlackRock Inc. BLK | 4,039,974 6.000% | 0 (Unchanged) | Filing History |
| 2024-11-07 09:24 am Purchase | 2024-11-06 | 13G | Perspective Therapeutics, Inc. CATX | FMR LLC | 9,496,225 14.083% | 3,991,403 (+72.51%) | Filing History |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | Perspective Therapeutics, Inc. CATX | FMR LLC | 5,504,822 8.164% | 5,504,822 (New Position) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Perspective Therapeutics, Inc. CATX | BlackRock Inc. BLK | 4,039,974 6.000% | 4,039,974 (New Position) | Filing History |
| 2024-04-19 4:05 pm Purchase | 2024-04-11 | 13G | Perspective Therapeutics, Inc. CATX | COMMODORE CAPITAL LP | 3,890,667 6.600% | 3,890,667 (New Position) | Filing History |
| 2024-03-08 11:22 am Purchase | 2024-03-06 | 13D | Perspective Therapeutics, Inc. CATX | Lantheus Holdings Inc. LNTH | 11,677,339 19.900% | 6,043,104 (+107.26%) | Filing History |
| 2024-02-05 7:18 pm Sale | 2023-12-31 | 13G | Perspective Therapeutics, Inc. CATX | Johnson Frances | 1,677,908 5.900% | -90,000 (-5.09%) | Filing History |
| 2024-02-05 5:35 pm Sale | 2023-12-31 | 13G | Perspective Therapeutics, Inc. CATX | Schultz Michael K | 1,677,908 5.900% | -90,000 (-5.09%) | Filing History |
| 2024-02-01 07:38 am Purchase | 2024-01-22 | 13D | Perspective Therapeutics, Inc. CATX | Lantheus Holdings Inc. LNTH | 5,634,236 10.740% | 5,634,236 (New Position) | Filing History |
| 2023-09-18 9:20 pm Purchase | 2023-02-03 | 13G | Perspective Therapeutics, Inc. CATX | Schultz Michael K | 1,767,908 6.300% | 1,767,908 (New Position) | Filing History |
| 2023-09-18 8:02 pm Purchase | 2023-02-03 | 13G | Perspective Therapeutics, Inc. CATX | Johnson Frances | 1,767,908 6.300% | 1,767,908 (New Position) | Filing History |